ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641297 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641297; 2) Community: the network communities that were significantly associated with the response to NSC 641297; 3) Molecule: the relationships between components within communities and NSC 641297; 4) MDR: the compounds that were significantly associated with the NSC 641297.

NSC Compound Enrichment Correlation
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0462077035966084 0.43315755
NSC 743556 Null 0.0462077035966084 0.10475016
NSC 18298 Null 0.0462077035966088 -0.20627974
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0462077035966088 -0.015570135
NSC 364830 Camptothecin Derivative 0.0462077035966088 0.068522378
NSC 338947 Clomesone 0.0467178916101838 0.062921407
NSC 56902 Null 0.0467178916101838 -0.16435343
NSC 637459 Macrocalyxoformin B (Rabdosia diterpenoids) 0.0467178916101838 0.16432825
NSC 655105 Cycloshikonin 0.046717891610184 0.23026831
NSC 657321 1,9-Dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone, 8,16-bis(2-oxopropyl)-, [8S-(3E,8R*,11E,16R*)]- 0.046717891610184 0.15295246
Total:114  Current:109    [First] [Prev] [Next] [Last]